Cart
sales@molnova.com
Carboxylesterase-IN-2
CAS No. 2764748-88-9
Carboxylesterase-IN-2( —— )
Catalog No. M36936 CAS No. 2764748-88-9
Carboxylesterase-IN-2 is a potent Carboxylesterase Notum inhibitor (IC50 <= 10 nM).Carboxylesterase-IN-2 has potential for the study of cancer diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 150 | In Stock |
|
| 5MG | 136 | In Stock |
|
| 10MG | 216 | In Stock |
|
| 25MG | 370 | In Stock |
|
| 50MG | 498 | In Stock |
|
| 100MG | 686 | In Stock |
|
| 200MG | 923 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCarboxylesterase-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCarboxylesterase-IN-2 is a potent Carboxylesterase Notum inhibitor (IC50 <= 10 nM).Carboxylesterase-IN-2 has potential for the study of cancer diseases.
-
DescriptionCarboxylesterase-IN-2 (compound 4u) is a potent inhibitor of Carboxylesterase Notum with an IC50 less than or equal to 10 nM. Notum is a negative regulator of Wnt signaling acting through the hydrolysis of a palmitoleoylate ester, which is required for Wnt activity. Carboxylesterase-IN-2 has the potential for the research of cancer disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorWnt/beta-catenin | Lipid
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2764748-88-9
-
Formula Weight272.33
-
Molecular FormulaC13H12N4OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (183.60 mM; Ultrasonic )
-
SMILESO=C1N2C(C=CC(SC3=CC(C)=C(C)C=C3)=N2)=NN1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Steadman D, et al. Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity. J Med Chem. 2022;65(1):562-578.?
molnova catalog
related products
-
WWL70
WWL70 is a selective alpha/beta hydrolase domain 6 inhibitors (IC50: 70 nM). WWL70 (10 μM, 1 h) treatment, 2-Arachidonoylglycerol is increased by 20% compared to untreated cells.
-
Delafloxacin
Delafloxacin (RX-3341, ABT-492) is a fluoroquinolone antibiotic agent. It has potent inhibitory against levofloxacin-resistant Streptococcus pneumoniae strains (MIC: 0.0078-0.125 μg/ml).
-
N-(3-Methoxybenzyl)-...
N-3-methoxylBenzyllinolenicamide induces osteogenic differentiation and subsequent bone formation of mesenchymal stem cells by activating the canonical Wnt/β-catenin signaling pathway that can be used for osteoporosis research.
